Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
HealthEquityFRA:2HE -3.85%97 Forward PE Ratio is 22.21 as of Aug. 03, 2026. GuruFocus rates FRA:2HE with a GF Score™ of 97/100 and a GF Value™ of €87.99 (Fairly Valued). The stock has 4 warning signs investors should review. Among 313 Healthcare Providers & Services companies, HealthEquity ranks worse than 56.87% on this metric.
HealthEquity's Forward PE Ratio for today is 22.21.
HealthEquity (FRA:2HE) Forward PE Ratio Explanation
The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.
Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .
HealthEquity Forward PE Ratio Related Terms
HealthEquity Forward PE Ratio Historical Data
* Premium members only.
The historical data trend for HealthEquity's Forward PE Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HealthEquity Forward PE Ratio Chart
HealthEquity Annual Data
Trend
2016-01
2017-01
2018-01
2019-01
2020-01
2021-01
2022-01
2023-01
2024-01
2025-01
2026-01
Forward PE Ratio
45.87
74.63
58.82
46.51
42.19
47.39
34.72
32.36
27.78
27.93
17.67
HealthEquity Quarterly Data
2016-01
2016-04
2016-07
2016-10
2017-01
2017-04
2017-07
2017-10
2018-01
2018-04
2018-07
2018-10
2019-01
2019-04
2019-07
2019-10
2020-01
2020-04
2020-07
2020-10
2021-01
2021-04
2021-07
2021-10
2022-01
2022-04
2022-07
2022-10
2023-01
2023-04
2023-07
2023-10
2024-01
2024-04
2024-07
2024-10
2025-01
2025-04
2025-07
2025-10
2026-01
2026-04
Forward PE Ratio
45.87
48.54
63.69
52.91
74.63
68.03
74.63
59.17
58.82
65.36
74.63
62.89
46.51
54.95
60.61
39.53
42.19
27.47
34.97
29.94
47.39
54.64
49.02
38.31
34.72
50.51
45.45
46.08
32.36
30.21
32.68
28.09
27.78
41.84
26.53
24.18
27.93
22.32
24.73
21.56
17.67
16.62
FRA:2HE vs TEM, TXG, HNGE: Forward PE Ratio Comparison
For the Health Information Services subindustry, HealthEquity's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
HealthEquity Forward PE Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, HealthEquity's Forward PE Ratio distribution charts can be found below:
* The bar in red indicates where HealthEquity's Forward PE Ratio falls into.
It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.
HealthEquity (FRA:2HE) has a Forward PE Ratio of 22.21 as of Aug. 03, 2026. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on HealthEquity and its competitors. According to the industry distribution chart, HealthEquity ranks #178 out of 313 companies in the Healthcare Providers & Services industry, placing it in the top 56.9%.
Is HealthEquity's Forward PE Ratio too high?
HealthEquity's current Forward PE Ratio is 22.21. The Healthcare Providers & Services industry median Forward PE Ratio is 18.50. HealthEquity's value of 22.21 is 20.1% above this industry median. Based on the distribution chart, HealthEquity ranks #178 out of 313 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, HealthEquity has a GF Score™ of 97/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does HealthEquity's Forward PE Ratio compare to TEM and TXG?
According to the Healthcare Providers & Services industry distribution chart, HealthEquity ranks #178 out of 313 companies for Forward PE Ratio. This places HealthEquity in the lower half of its industry. The industry median Forward PE Ratio is 18.50. HealthEquity's value of 22.21 is 20.1% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward PE Ratio for a Healthcare Providers & Services company?
The median Forward PE Ratio among Healthcare Providers & Services companies is 18.50, based on 313 companies in the industry. Companies in the top quartile (top 25%) have a Forward PE Ratio significantly above this median, while those in the bottom quartile fall well below. However, Forward PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. HealthEquity's current Forward PE Ratio of 22.21 is 20.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward PE Ratio mean?
A high Forward PE Ratio can signal that a stock is expensive relative to its fundamentals. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on HealthEquity and its competitors. For the Healthcare Providers & Services industry, the median Forward PE Ratio is 18.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. HealthEquity's current Forward PE Ratio is 22.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HealthEquity stock overvalued right now?
Based on GuruFocus' analysis, HealthEquity (FRA:2HE) is currently considered Fairly Valued. The stock's GF Value™ is €87.99, compared to a current price of €87.50 — trading 0.6% below its estimated fair value. The current Forward PE Ratio is 22.21 and 20.1% above the Healthcare Providers & Services industry median of 18.50. HealthEquity's overall GF Score™ is 97/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward PE Ratio calculated?
Forward PE Ratio is calculated from a company's financial statements. For HealthEquity (FRA:2HE), the current Forward PE Ratio is 22.21 as of Aug. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is HealthEquity (FRA:2HE) Overvalued in 2026?
Based on GuruFocus' analysis, HealthEquity stock appears to be undervalued.
The current stock price of €87.50 is trading 0.6% below its estimated GF Value™ of €87.99.
GuruFocus considers HealthEquity to be Fairly Valued.
Key valuation signals for FRA:2HE:
Forward PE Ratio: 22.21
GF Value™: €87.99 vs. price of €87.50 (0.6% below fair value)
Industry Position: 20.1% above the Healthcare Providers & Services median (#178 of 313)
No single metric tells the full story. See the FRA:2HE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. It provides payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice to grow their tax-advantaged healthcare savings. It manages consumers' tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and administers Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It also provides investment advisory services to customers whose account balances exceed a certain threshold. HealthEquity generates its revenue in the United States.
97GF Score
Get the complete analysis for FRA:2HE
Forward PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:2HE has been successfully added to your 
